HRH Princess Chulabhorn signed a Memorandum of Understanding between the Chulabhorn Research Institute and the Government Pharmaceutical Organization (21 May 2009)

Professor Dr. Her Royal Highness Princess Chulabhorn, President of the Chulabhorn Research Institute, graciously presided at a signing ceremony of a Memorandum of Understanding between the Chulabhorn Research Institute (CRI) and the Government Pharmaceutical Organization (GPO) to collaborate in the production of new medicines on 21 May 2009.

Her Royal Highness signed the agreement as the president of the Chulabhorn Research Institute and Dr. Witi Achvatkun signed as the director of the Government Pharmaceutical Organization.

The agreement promoted research into the development of new medicines. Both organizations undertook to collaborate in the research and development of high quality medicines that could be produced in Thailand and made available at a reasonable price.

The Chulabhorn Research Institute came under the Chulabhorn Foundation, which also incorporated the Chulabhorn Graduate Institute and the Chulabhorn Cancer Centre together providing state of the art research facilities while the Government Pharmaceutical Organization had earned the highest reputation in quality control and the production and marketing of medicinal products.

Under the terms of the agreement, collaboration focused on new approaches and techniques in biotechnology for the production of drugs such as erythropoietin, a medicine used in the treatment of renal failure.